Skip to content

Drug interactions

Ribociclib + Tazemetostat

Severity: Moderate

Ribociclib and Tazemetostat: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ribociclib inhibits CYP3A4 and may increase tazemetostat exposure, raising the risk of its adverse effects. Tazemetostat labeling advises avoiding moderate CYP3A inhibitors or reducing the dose.

What this interaction means in plain words

Ribociclib and Tazemetostat can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ribociclib belongs to Oncology; Tazemetostat belongs to Miscellaneous.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4-mediated metabolism of tazemetostat by ribociclib.

What to do

Avoid if possible; if combined, reduce the tazemetostat dose per labeling and monitor for toxicity. Restore the dose after stopping the inhibitor for about three half-lives.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ribociclib and Tazemetostat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ribociclib with Tazemetostat?

MediHelp rates the interaction as moderate. Ribociclib and Tazemetostat can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ribociclib inhibits CYP3A4 and may increase tazemetostat exposure, raising the risk of its adverse effects. Tazemetostat labeling advises avoiding moderate CYP3A inhibitors or reducing the dose.

How serious is the interaction between Ribociclib and Tazemetostat?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible; if combined, reduce the tazemetostat dose per labeling and monitor for toxicity. Restore the dose after stopping the inhibitor for about three half-lives.

What other medicines interact with Ribociclib?

MediHelp also lists interactions of Ribociclib with, for example, Amiodarone, Cisapride, Dofetilide. The full list is on the Ribociclib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in